Answers are grounded in this paper and cite their sources.
Insights reveal CNS-specific biomarker responses to PPARγ and GLP1 receptor agonists, indicating significant metabolic changes.
Our findings demonstrate CNS-specific biomarker responses to both PPARγ agonists and GLP1 receptor agonists.
No takes yet. Share an insight, caveat, or question.
Evers et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: